These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9588915)

  • 1. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Pai HH; Rochon L; Clark B; Black M; Shenouda G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer.
    Narayana A; Vaughan AT; Kathuria S; Fisher SG; Walter SA; Reddy SP
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):21-6. PubMed ID: 10656367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy.
    Schrijvers ML; Pattje WJ; Slagter-Menkema L; Mastik MF; Gibcus JH; Langendijk JA; van der Wal JE; van der Laan BF; Schuuring E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1220-6. PubMed ID: 22208968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?
    Narayana A; Vaughan AT; Gunaratne S; Kathuria S; Walter SA; Reddy SP
    Cancer; 1998 Jan; 82(2):286-91. PubMed ID: 9445184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 overexpression in head and neck carcinoma and radiotherapy results.
    Awwad S; Jaros E; Somes J; Lunec J
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):323-32. PubMed ID: 8567333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.
    Korkmaz H; Du W; Yoo GH; Enamorado II; Lin HS; Adsay V; Kewson D; Ensley JF; Shibuya TY; Jacobs JR; Kim H
    Am J Otolaryngol; 2005; 26(2):77-82. PubMed ID: 15742257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy.
    Kokoska MS; Piccirillo JF; el-Mofty SK; Emami B; Haughey BH; Schoinick SB
    Cancer; 1996 Oct; 78(8):1693-700. PubMed ID: 8859182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
    Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
    Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of EGF receptor expression in early glottic cancer.
    Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
    Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between epidermal growth factor receptor (EGFR) and p53 expression and radiocurability of laryngeal squamous cell cancer].
    Dupla D; Fraczek M; Woźniak Z; Krecicki T
    Otolaryngol Pol; 2009; 63(3):249-55. PubMed ID: 19886531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
    Matsumoto F; Ohba S; Fujimaki M; Ikeda K
    Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.